What question did this study set out to answer?

The research aims to explore how stimulation and medication affect beta oscillations in the subthalamic nucleus of Parkinson's disease patients.

March 13, 2026

View Full Paper

Stimulation and Medication Effects on Subthalamic Nucleus Beta‐Band Power in Parkinson's Disease: Implications for Adaptive Deep Brain Stimulation

LHLauren H. HammerUniversity of California, San Francisco SCStephanie CerneraUniversity of California, San Francisco COCarina R. OehrnUniversity of California, San Francisco

Key Points

The research aims to explore how stimulation and medication affect beta oscillations in the subthalamic nucleus of Parkinson's disease patients.
Analyzed spectral characteristics of beta oscillations
Investigated effects of different stimulation conditions
Assessed medication influence on beta-band power
Beta oscillations in the subthalamic nucleus vary based on stimulation and medication
Findings support beta power as a biomarker for adaptive deep brain stimulation

Abstract

The spectral characteristics of STN beta oscillations and their performance as a biomarker in aDBS for Parkinson's disease are influenced by the stimulation and medication conditions in which it is implemented. © 2026 International Parkinson and Movement Disorder Society.

AIに質問

Bookmark

View Full Paper

AIに質問

Bookmark

View Full Paper

Stimulation and Medication Effects on Subthalamic Nucleus Beta‐Band Power in Parkinson's Disease: Implications for Adaptive Deep Brain Stimulation

Key Points

Abstract

Cite This Study

Also Consider

Also Consider